406 related articles for article (PubMed ID: 31849033)
1. Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age.
Raheemullah A; Andruska N
J Opioid Manag; 2019; 15(5):428-432. PubMed ID: 31849033
[TBL] [Abstract][Full Text] [Related]
2. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
3. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
4. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
5. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
[TBL] [Abstract][Full Text] [Related]
6. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
7. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
8. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
[TBL] [Abstract][Full Text] [Related]
9. The fentanyl phase of the opioid epidemic in Cuyahoga County, Ohio, United States.
Deo VS; Gilson TP; Kaspar C; Singer ME
J Forensic Sci; 2021 May; 66(3):926-933. PubMed ID: 33394503
[TBL] [Abstract][Full Text] [Related]
10. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.
Ali SA; Shell J; Harris R; Bedder M
Harm Reduct J; 2023 Oct; 20(1):144. PubMed ID: 37798673
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.
Somerville NJ; O'Donnell J; Gladden RM; Zibbell JE; Green TC; Younkin M; Ruiz S; Babakhanlou-Chase H; Chan M; Callis BP; Kuramoto-Crawford J; Nields HM; Walley AY
MMWR Morb Mortal Wkly Rep; 2017 Apr; 66(14):382-386. PubMed ID: 28406883
[TBL] [Abstract][Full Text] [Related]
12. Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History.
Abbasi AB; Salisbury-Afshar E; Jovanov D; Berberet C; Arunkumar P; Aks SE; Layden JE; Pho MT
J Urban Health; 2019 Feb; 96(1):38-48. PubMed ID: 30607879
[TBL] [Abstract][Full Text] [Related]
13. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
[No Abstract] [Full Text] [Related]
14. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
[TBL] [Abstract][Full Text] [Related]
15. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
[TBL] [Abstract][Full Text] [Related]
16. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for severe respiratory depression from prescription opioid overdose.
Fox LM; Hoffman RS; Vlahov D; Manini AF
Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
[TBL] [Abstract][Full Text] [Related]
18. Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.
Amaducci A; Aldy K; Campleman SL; Li S; Meyn A; Abston S; Culbreth RE; Krotulski A; Logan B; Wax P; Brent J; Manini AF;
JAMA Netw Open; 2023 Aug; 6(8):e2331264. PubMed ID: 37642962
[TBL] [Abstract][Full Text] [Related]
19. Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance.
Shover CL; Falasinnu TO; Dwyer CL; Santos NB; Cunningham NJ; Freedman RB; Vest NA; Humphreys K
Drug Alcohol Depend; 2020 Nov; 216():108314. PubMed ID: 33038637
[TBL] [Abstract][Full Text] [Related]
20. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose.
Krotulski AJ; Chapman BP; Marks SJ; Ontiveros ST; Devin-Holcombe K; Fogarty MF; Trieu H; Logan BK; Merchant RC; Babu KM
Clin Toxicol (Phila); 2022 Feb; 60(2):197-204. PubMed ID: 34278904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
